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Summary 
Diabetes is currently the world’s fastest growing chronic disease and it is caused by deficient production 
of insulin by the endocrine pancreas or by abnormal insulin action in peripheral tissues. This results in 
persistent hyperglycemia that over time may produce chronic diabetic complications. Determination of 
glycated hemoglobin level is currently the gold standard method to evaluate and control sustained 
hyperglycemia in diabetic people. This measurement is currently made by high-performance liquid 
chromatography (HPLC), which is a complex chemical process that requires the extraction of blood from 
the antecubital vein. To reduce the complexity of that measurement, we propose a fully-optical technique 
that is based in the fact that there are changes in the optical properties of erythrocytes due to the presence 
of glucose-derived adducts in the hemoglobin molecule. To evaluate these changes, we propose to 
perform quantitative phase maps of erythrocytes by using telecentric digital holographic microscopy 
(DHM). Our experiments show that telecentric DHM allows detecting, almost in real time and from a 
single drop of blood, significant differences between erythrocytes of diabetic patients and healthy 
patients. Besides, our phase measurements are well correlated with the values of glycated hemoglobin and 
the blood glucose values. 
Introduction 
Diabetes mellitus (DM) is a disease that includes a series of metabolic alterations that affect different 
organs and tissues (Maahs et al., 2010; Chen et al., 2011). In 2013, 382 million people around the world 
were affected with diabetes and according to the International Diabetes Federation (IDF) and the World 
Health Organization (WHO) this metabolic disorder is expected to affect 592 million people in 2035 
(Maahs et al., 2010; Chen et al., 2011). Diabetes is mainly due to a deficient production of insulin by the 
endocrine pancreas or by abnormal insulin action in peripheral tissues. Diabetes is generally classified 
into four broad categories (Maraschin, 2012): type 1, type 2, gestational diabetes and others. Type 1 and 
type 2 are the most prevalent and therefore responsible for the majority of the health care cost attributed 
to this disease. Type 1 diabetes mellitus (T1DM) is characterized by the almost total loss of insulin due to 
an autoimmune destruction of pancreatic beta cells (Boitard, 2012). Therefore, type 1 diabetic patients 
require lifelong insulin injections, since there are no alternative hormones in the organism that can mimic 
the effect of insulin. 
In any case, insulin injections cannot replace the exquisite control exerted by the pancreatic beta-cells that 
secrete the hormone in response to glucose variations in blood in a dose-dependent manner (Malik et al., 
2014). For this reason, patients with T1DM present prominent fluctuations in blood glucose, with longer 
periods of hyperglycemia compared to non-diabetic individuals (Korytkowski, 2013; Lee, 2013; Todi, 
2014). This may result over time in the development of secondary complications that affect mainly the 
retina, kidneys, nerves and cardiovascular system (Forbes et al., 2013). Therefore, hyperglycemia control 
is one of the main objectives to minimize the risk of developing retinopathy, nephropathy, neuropathy 
and cardiovascular complications (Korytkowski, 2013; Todi, 2014). Plasma glucose measurements based 
on dry chemistry and performed by a glucometer are quite accurate and minimally invasive, requiring 
only a drop of blood. However, these determinations, performed 4-6 times per day by the own patient, 
provide only a prompt index of the circulating glucose. 
Long-term glycemic control is evaluated in terms of glycated hemoglobin (HbA1C) concentration 
(International Expert Committee, 2009). High glucose concentration in blood results in non-enzymatic 
glycation of side-chain amino groups of the amino acid residues, such as lysine, of circulating proteins. 
Glycation rate increases with higher concentrations of the sugar. The concentration of HbA1C indicates 
the level of exposure to persistent hyperglycemia over the last 2-3 months, coinciding with the half-life of 
hemoglobin (approximately 120 days). Therefore, HbA1C is the gold standard parameter to evaluate 
periodically glycemic control in patients with diabetes (International Expert Committee, 2009). HbA1C is 
measured currently by high-performance liquid chromatography (HPLC), and expressed both in % or in 
International Federation of Clinical Chemistry (IFCC) units (mmol/mol) (Consensus Committed, 2007). 
Recently, the American Diabetes Association (ADA) as well as other institutional bodies have adopted 
HbA1C levels as diagnostic of diabetes if above 6.5 % (American Diabetes Association, 2010). 
In this work, we propose a novel, fully-optical technique for the easy evaluation of HbA1C 
concentrations, and therefore for obtaining a fast screening of T1DM levels. This study is motivated by 
two previous published works (Mazarevica et al., 2002, Okamoto et al., 2000) which show that the 
refractive properties vary in presence of DM. In fact, Mazarevica et al. demonstrated a relationship 
between the refractive index, which is measured using a Nomarski polarizing-interference microscope, 
and pH level for diabetic and healthy donors. On the other hand, Okamoto et al. verified that variations in 
plasma glucose causes refractive index changes in eyes of diabetic subjects and, as a result, transient 
myopia or hyperopia is derived. Based on their findings, it seems logical to hypothesize that the phase of 
red blood cells (RBCs) could also change. Our method is based in the use of a telecentric DHM for the 
acquisition of quantitative phase maps of erythrocytes samples obtained from patients affected by 
diabetes, and also from non-diabetic (named as controls) individuals. After analyzing the alterations in the 
phase distributions we have found that there is a strong correlation between the absolute phase value of 
RBCs and the corresponding values of HbA1C. This correlation permits us to suggest the use of 
telecentric DHM to quantify persistent hyperglycemia states. Besides, since only a small drop of blood is 
required and the phase measurement can be performed in any time, we can adopt this technique as a first-
screening method for the diagnosis of abnormal hyperglycemia . 
Material and methods 
Sample preparation 
Samples were obtained from both non-diabetic individuals (controls) and also from patients with T1DM 
who have been under treatment with insulin injections over a period of 23 ± 10 years (mean ± standard 
deviation). Capillary blood specimens from patients with T1DM were collected during routine 
ambulatory visits at the Diabetes Reference Center from the Clinic Hospital of Valencia (Spain). Control 
samples were obtained in a certified clinical analysis laboratory, Elche (Spain). All individuals 
participated voluntarily in this study, being adequately informed about the conditions and the purpose of 
the assessment. Participants signed an informed consent approved by the Ethics Committee of the 
University Miguel Hernández (Elche, Spain), fulfilling the requirements of the Declaration of Helsinki 
regarding human research. 
Clinical measurements of HbA1C were performed using HPLC of blood extracted from the antecubital 
vein. On the other hand, telecentric DHM was performed, at the 3D Imaging and Display Laboratory 
(University of Valencia), on a capillary blood drop smearing on a glass slide. The smeared blood was 
dried out at room temperature in a dust-free environment. After the sample preparation, each slide was 
placed properly in the optical object path of our off-axis transmission telecentric DHM and a hologram 
was captured for each sample. The time required for the DHM operation and data processing did not 
exceed one minute per sample. 
Telecentric DHM 
The telecentric DHM was mounted, in open configuration, on an optical table. The scheme is shown in 
Figure 1. A He-Ne laser (wavelength λ = 633 nm, 50 mW output power, random polarization, by Edmund 
Optics) was used as the illumination source. The light proceeding from the laser was collimated and split 
to produce the reference (R) and object waves (O). A Nikon Plan Epi 50×/0.55 NA microscope objective 
(MO) and a tube lens (TL) of focal length fTL = 200 mm were placed in the object arm of the microscope. 
A CCD camera with 1024 × 1024 square pixels of 6.9 µm in side, recorded the holograms formed by the 
interference between the wavefield diffracted by the sample and a reference plane wave R. In order to 
operate in single-shot mode, the DHM was arranged in off-axis geometry by slightly tilting the reference 
wave R. The beam-splitter BS2 and the mirror M2 controlled the tilt angle. Note that the DHM operated 
in a telecentric regime in order to provide accurate quantitative phase measurements (Doblas et al., 2013; 
Doblas et al., 2014). A detailed description of the image formation procedure and the reconstruction 
process have been carefully given in Refs. (Doblas et al., 2014) and (Sánchez-Ortiga et al., 2014). 
Since DHM is a holographic method, the computational reconstruction of the object wave follows well-
established and exact methods. Specifically, to retrieve the object information, it is necessary to filter out 
the Fourier transform of the object information from the hologram spectrum, and then to perform the 
inverse Fourier transform. It is worth to mention that in our scheme the CCD is placed at the image plane 
of the imaging system, see Figure 1, and therefore not back-propagation algorithms are required (Kim, 
2011; Kreis, 2004; Picart & Li, 2012, Popescu, 2011). The computational processing of the digital 
holograms to provide a quantitative phase map of the sample was performed using Matlab (Mathworks, 
Natick, MA). 
Stability analysis 
As it is well known, phase measurements are strongly dependent on ambient fluctuations. To provide a 
controlled environment during the holograms acquisition, the complete microscope has been enclosed in a 
polymethymethacrylate (PMMA) cage with its temperature controlled. To exclude any incidence of 
ambient perturbations on the results of the experiment, we initially tested the stability of the set-up by 
recording twenty-five holograms of a test sample over a period of 5 minutes. From the twenty-five 
holograms, we calculated the corresponding twenty-five phase maps. Using these maps, the mean value 
of the phase over an area free of RBCs information was measured. It is worth to mention that the size of 
the area used to compute the mean phase was 41 × 41 µm2. For this region, the obtained value was 1.591 
± 0. 013 rad. From the small value of the standard deviation (0.013 rad), we concluded that our DHM 
system was fairly isolated from ambient fluctuations to guarantee trustable measurements for at least 5 
minutes and, thus, any divergence between the measurements would be due to differences on the samples. 
Statistical analysis 
Non-parametric tests were used since the sample was small and, consequently, the variables were not 
normally distributed. Mann-Whitney (Hollander et al., 1999; Randolph et al., 2013) test was used to 
assess differences between control and diabetes groups with each one of the diagnostic methods (DHM 
and HPLC). Correlations between methods were later computed by means of the Spearman rho test 
[23,24]. Note that the statistical tests can be interpreted using p-values (Hollander et al., 1999; Randolph 
et al., 2013). The p-value is the probability of obtaining a test statistic result at least as extreme as the one 
that was actually observed, assuming that the null hypothesis is true. If the p-value is less than the 
required significance level, then one says the null hypothesis is rejected at the given level of significance. 
The lower significance level the stronger presumption against null hypothesis. All data were statistically 
analyzed using the SPSS software (version 22.0). 
Results and Discussion 
Table 1 summarizes the main characteristics of the population participating in the study. The total number 
of participants was 43, separated into 14 controls (9 men and 5 women) and 29 T1DM patients (13 men 
and 16 women). The results shown in Table 1 indicate that blood glucose and HbA1C values of the 
control group are much more homogeneous, in contrast to the values obtained from the T1DM group. 
 
Table 1 Basic characteristics (mean, standard deviation and range) of the sample under research. 








Age (year) 33 14 22-58 41 8 21-55 
Height (cm) 170 10 151-190 168 7 158-185 
Weight (kg) 74 15 53-97 73 12 55.5-96.7 
Glucose (mg/dl) 85 12 63-120 171 77 24-408 
HbA1C (%) 5.2 0.3 4.8-6.0 8.3 0.8 6.10-10.3 
 
Using our telecentric DHM we measured the phase maps of RBC samples from both the healthy control 
group and the T1DM patients. As illustrating example of the results we obtained, in Figure 2 we show the 
phase maps corresponding to three controls and to three patients. For better visualization, the images have 
been pseudo-colored using the same color scale. From these samples, it is apparent that phase values of 
healthy RBCs are significantly smaller than those obtained for the T1DM group. The phase maps were 
used to calculate a mean phase value for each participant. For each RBC the phase was obtained as the 
average value over a square area of approximately 1.12 × 1.12 µm2 surrounding the centroid of the RBC. 
The phase values of 20 erythrocytes were averaged to obtain the phase value for each individual of the 
test. Owing to the sample preparation, the measured phase includes contributions not only from the RBCs 
but also from the plasma components. To remove the latter, the average value of the phase over the areas 
free of RBCs is subtracted from the total phase. This procedure was indeed applied to the phase maps 
show in Figure 2, hence the phase value over the RBCs is essentially provided by the optical path length 
along the blood cells. It is worth to mention that the stripe-like patterns in Figure 2 are due to the non-
unlimited accuracy of the digital holographic microscope. 
Figure 3 shows the histograms of the RBC phases from healthy individuals and for diabetic patients. The 
mean values were 3.15 ± 0.13 rad and 3.72 ± 0.15 rad, respectively. Clearly, the phase values in the 
T1DM group were significantly higher than in the healthy control group. In addition, there is a big gap 
between the phase values of the two groups, see in Figure 3 that the phase values ranged 2.94 - 3.30 rad 
for healthy RBCs and 3.51 - 4.01 rad for T1DM RBCs. It is then reasonable to claim that the phase 
measurement made with telecentric DHM permits to divide the population into groups of healthy or 
T1DM patients and, moreover, phase values above 3.40 rad are an indication of hyperglycemia. Another 
way to ensure this conclusion, and perhaps even the most formal way, is by applying the Mann-Whitney 
test, which tells us if the phase values from both groups are independent of each other. It is important to 
realize that this test shows greater efficiency than the regular t-test (Hollander et al., 1999; Randolph et 
al., 2013) on non-normal distributions, see in Figure 3 that our phase distributions are not Gaussian. 
Using the Mann-Whitney test, we found that the phase distributions of both groups are statistically 
independent with a very high significance level (p < 0.001). 
 
As a proof of the validity of the diabetes screening with telecentric DHM, we have contrasted the DHM 
results with the HbA1C values, which is the gold standard to assess diabetic patients. In Figure 4 we have 
plotted the phase vs. the HbA1C values for all the population under study. We measured the rho 
correlation coefficient to obtain rho=0.739, with p < 0.01. The high correlation coefficient and the clear 
separation between the two populations confirm that both parameters may potentially be used to diagnose 
diabetes states as well as to evaluate long-term glycemic control in patients with diabetes. This result can 
be explained by accepting the findings by Barer et al. (Barer, 1952) which demonstrated that hemoglobin 
concentration is directly related to phase values. Although, from Figure 5, it seems that both DHM and 
HPLC should be individually sufficient to separate out the two populations, it is worth to highlight that 
using both approaches would allow for even better screening of DM. Besides, DHM technique could be 
used as the first method since only a capillary blood drop is needed, it can be performed in any time and 
the phase measurement is obtained in a fairly instantaneous way. 
Conclusions 
In this paper is demonstrated, for the first time to our knowledge, the use of telecentric DHM for diabetes 
screening. The utility of the DHM results from the possibility of providing quantitative phase maps as 
indicators of long-term blood sugar control similar to HbA1C. Although a strictly-medical research 
would require the analysis of much more individuals, our results should be viewed as a proof-of-concept 
study. In addition, the proposed method shows great potential as optional tool to screen for diabetes 
because: (1) it is a minimally invasive technique since only a small drop of capillary blood is needed; (2) 
it can be performed at any time and the results can be obtained almost in real time; and (3) it is a wide-
field technique which can be easily implemented in a conventional microscope (Sánchez-Ortiga et al., 
2015) and can be used to analyze illnesses in which the refractive index or/and the morphology are 
distorted (Byun et al., 2012; Kemper et al., 2010; Park et al., 2008; Pavillon et al., 2012; Sridharan et al., 
2015). 
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